SUMO2 and heart failure: Importantly, both studies also reported a marked increase in SUMO2/3-mediated sumoylation in the hearts of human patients suffering from dilated, ischemic, or hypertrophic cardiomyopathy6,25, pointing towards a broader pathogenic role of SUMO2 in the development of heart failure.